Us Congress House Bill HB124

Us Congress 2023-2024 Regular Session

• Introduced: 1/9/23
• Refer: 1/9/23
• Refer: 1/20/23

Caption

Byron Nash Renal Medullary Carcinoma Awareness Act of 2023 This bill allows states to receive federal payment under Medicaid for 50% of their costs for providing education on the risk of renal medullary carcinoma to individuals with sickle cell disease. (Renal medullary carcinoma is a rare kidney disease usually found in individuals with the sickle cell trait.)

Impact

If enacted, HB124 would specifically amend Title XIX of the Social Security Act to include provisions that support educational initiatives about renal medullary carcinoma. This bill is anticipated to ameliorate the existing gaps in awareness that might otherwise lead to undetected or poorly managed cases of this rare disease. By empowering healthcare providers and Medicaid participants with vital information, the legislation aims to improve early detection and treatment outcomes for those affected.

Summary

House Bill 124, known as the Byron Nash Renal Medullary Carcinoma Awareness Act of 2023, aims to enhance awareness and education about the risks associated with renal medullary carcinoma among individuals with sickle cell disease who are receiving medical assistance through Medicaid. This initiative acknowledges the rare but serious nature of renal medullary carcinoma, which primarily affects individuals with the sickle cell trait, particularly emphasizing the need for improved patient education in this demographic. The bill proposes to allow states to receive federal payment for half of their expenses incurred while providing this educational service.

Contention

While the bill primarily garners support for its noble aim of increasing health education, potential points of contention may arise regarding the funding allocation and the enhanced responsibilities it places on state Medicaid programs. Critics might argue about the efficacy and practicality of implementing educational programs, especially in states with limited resources or differing health priorities. Furthermore, there could be debates over the inclusion of this specific disease in Medicaid education services amidst calls for broader health education initiatives.